Publications by authors named "Christelle Audrain"

Claim this Profile
C
Characterization of Digestive Manifestations in Patients with Impaired PTH/PTHrP Signaling Disorder/Pseudohypoparathyroidism.
Agnès Linglart, Bérénice Goy, Jugurtha Berkenou, Anya Rothenbuhler, Christelle Audrain

Horm Res Paediatr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burosumab prevents further height deficit in toddlers affected by XLH.
Elisa Sala, Jugurtha Berkenou, Anya Rothenbuhler, Anne-Sophie Lambert, Christelle Audrain

Endocr Connect· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study.
Emese Boros, Diana-Alexandra Ertl, Jugurtha Berkenou, Christelle Audrain, Anne Lise Lecoq

Eur J Endocrinol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations.
Diana-Alexandra Ertl, Guiomar Perez de Nanclares, Harald Jüppner, Patrick Hanna, Angela Pagnano, Christelle Audrain

Eur J Endocrinol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Young XLH Patients-Reported Experience with a Supportive Care Program.
Anya Rothenbuhler, Iva Gueorguieva, Lydia Lichtenberger-Geslin, Christelle Audrain, Sylvie Soskin

Patient Prefer Adherence· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone.
Diana-Alexandra Ertl, Justin Le Lorier, Andreas Gleiss, Séverine Trabado, Candace Bensignor, Christelle Audrain

Orphanet J Rare Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance imaging is a valuable tool to evaluate the therapeutic efficacy of burosumab in children with X-linked hypophosphatemia.
Volha V Zhukouskaya, Inès Mannes, Catherine Chaussain, Peter Kamenický, Christelle Audrain

Eur J Endocrinol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGF23 measurement in burosumab-treated patients: an emerging treatment may induce a new analytical interference.
Marie-Liesse Piketty, Severine Brabant, Jean-Claude Souberbielle, Gérard Maruani, Christelle Audrain

Clin Chem Lab Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased prevalence of overweight and obesity in children with X-linked hypophosphatemia.
Volha V Zhukouskaya, Anya Rothenbuhler, Annamaria Colao, Carolina Di Somma, Peter Kamenický, Christelle Audrain

Endocr Connect· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis